Compare Cassava Sciences Inc (FLNA) vs Rivian Automotive, Inc. (RIVN) Price & Performance

FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.

Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.

Rivian stock trades at $16.91, down 3.37% on the day, as the EV maker continues its transition toward profitability. Recent earnings beats and the upcoming R2 vehicle launch provide optimism, though negative cash flow and substantial losses remain concerns. Technical indicators show a bullish trend with support at $16 and resistance at $18-19, while analyst consensus favors a buy rating with a $19.22 price target.

The investment case hinges on Rivian's ability to scale production and achieve profitability, with the R2 launch representing a potential inflection point. Key risks include ongoing cash burn, competitive pressures, and execution challenges in a capital-intensive industry. Upside potential exists if the company can demonstrate sustainable margin improvement and demand strength for new models.